The Vanguard Group 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 1:30 pm Unchanged |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 10,639,440 7.210% |
0 (Unchanged) |
Filing |
| 2024-11-04 10:58 am Sale |
2024-09-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 10,639,440 7.210% |
-2,128,244 (-16.67%) |
Filing |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 12,767,684 8.820% |
973,516 (+8.25%) |
Filing |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 11,794,168 8.250% |
762,880 (+6.92%) |
Filing |
| 2022-02-09 3:16 pm Purchase |
2021-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 11,031,288 7.820% |
1,375,863 (+14.25%) |
Filing |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT |
The Vanguard Group | 9,655,425 7.060% |
9,655,425 (New Position) |
Filing |